Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 3
2005 6
2006 2
2007 4
2008 2
2009 4
2010 4
2011 4
2012 2
2013 3
2014 1
2015 4
2016 3
2017 4
2018 7
2019 7
2020 12
2021 10
2022 20
2023 17
2024 8
2025 6
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

128 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacokinetic Comparability Assessment of Tixagevimab and Cilgavimab Developed for COVID-19 Prevention and Treatment Using Standard Exposure Metrics and Partial Area Under the Curve.
Zhang H, Tang W, Sadow S, Baronio R, Tullio AN, Hirao L, Dzutseva V, Chen CC, Kiazand A, Chang LJ, Cohen TS, Gibbs M. Zhang H, et al. Among authors: gibbs m. Clin Pharmacokinet. 2026 May;65(5):747-761. doi: 10.1007/s40262-026-01631-7. Epub 2026 Mar 31. Clin Pharmacokinet. 2026. PMID: 41917376 Free PMC article. Clinical Trial.
Rapid Elimination of Culturable SARS-CoV-2 With Intramuscular or Intravenous Administration of Antiviral Monoclonal Antibody Therapy.
Deo R, Choudhary MC, Glover OT, Ignacio RB, Boucau J, Chew KW, Moser C, Currier JS, Eron JJ, Javan AC, Giganti MJ, Aga E, Gibbs M, Cohen T, Streicher K, Soboleva K, Fletcher CV, Daar ES, Greninger AL, Coombs RW, Fischer W, Hughes MD, Smith D, Wohl DA, Barczak AK, Li JZ. Deo R, et al. Among authors: gibbs m. Open Forum Infect Dis. 2025 Sep 8;12(9):ofaf542. doi: 10.1093/ofid/ofaf542. eCollection 2025 Sep. Open Forum Infect Dis. 2025. PMID: 40980587 Free PMC article.
Letter of Concern from the Association of Academic Chairs of Emergency Medicine Regarding ACGME Proposed Changes.
Hamilton RJ, Becker LB, Wolfe RE, Algren DA, Arnold T, Baumann M, Berkeley RP, Caffery TS, Cannon CM, Corbin TJ, Chansky ME, Dhindsa HS, Emerman CL, Farcy DA, Fox C, Gibbs MA, Goode CS, Godwin SA, Jehle D, Johnson D, Keim SM, Khazaeni B, Knapp BJ, Hawthorne C, Hoyle JD Jr, Kurz MC, Leibner E, McNamara R, McCormack RF, Michelson EA, Miller C, Norse A, Nugent A, O'Neil BJ, Overton DT, Panacek EA, Paolo WF, Pauzé DR, Perez AL, Riviello RJ, Rodi SW, Pang PS, Gonzalez Sanchez JA, Seaberg D, Schwartz A, Shiver SA, Sklar DP, Smith BC, Stowell JR, Squillante MD, Thomas JJ, Hoek TV, Volturo GA, Walters EL, Wyatt TE, Yealy DM. Hamilton RJ, et al. Among authors: gibbs ma. West J Emerg Med. 2025 Jun 27;26(4):769-772. doi: 10.5811/westjem.48840. West J Emerg Med. 2025. PMID: 40795015 Free PMC article.
Tixagevimab/cilgavimab or placebo for COVID-19 in ACTIV-2: Safety, pharmacokinetics and neutralizing and anti-drug antibodies.
Bender Ignacio RA, Chew KW, Moser C, Currier JS, Eron JJ, Javan AC, Giganti MJ, Ritz J, Gibbs M, Kouekam HT, Esser MT, Daar ES, Choudhary M, Deo R, Fletcher CV, Li JZ, Hughes MD, Smith D, Wohl DA; ACTIV-2/A5401 Study Team. Bender Ignacio RA, et al. Among authors: gibbs m. iScience. 2025 Feb 4;28(3):111938. doi: 10.1016/j.isci.2025.111938. eCollection 2025 Mar 21. iScience. 2025. PMID: 40124489 Free PMC article.
Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trial.
Haidar G, Thomas S, Loubet P, Baker RI, Benfield T, Boonyaratanakornkit J, Kiertiburanakul S, Kim AHJ, Longbrake EE, Molina JM, Paredes R, Tucker D, Uriel A, Weinmann-Menke J, Aksyuk AA, Clegg LE, Currie A, Yang H, Flyrin K, Gibbs M, Shroff M, Perez JL, Chang LJ, Cohen TS; SUPERNOVA study group. Haidar G, et al. Among authors: gibbs m. Lancet Infect Dis. 2025 Jul;25(7):813-826. doi: 10.1016/S1473-3099(24)00804-1. Epub 2025 Feb 24. Lancet Infect Dis. 2025. PMID: 40015292 Clinical Trial.
Assessment of sociodemographic factors associated with time to self-reported COVID-19 infection among a large multi-center prospective cohort population in the southeastern United States.
Beron AJ, Yukich JO, Berry AA, Correa A, Keating J, Bott M, Wierzba TF, Weintraub WS, Friedman-Klabanoff DJ, Mongraw-Chaffin M, Gibbs MA, Taylor YJ, Kissinger PJ, Hayes DV, Schieffelin JS, Burke BK, Oberhelman RA. Beron AJ, et al. Among authors: gibbs ma. PLoS One. 2024 Sep 6;19(9):e0293787. doi: 10.1371/journal.pone.0293787. eCollection 2024. PLoS One. 2024. PMID: 39240796 Free PMC article.
128 results